Non-specific amplification of patient-specific Ig/TCR gene rearrangements depends on the time point during therapy: implications for minimal residual disease monitoring.
van der Velden
V H J
VH
Wijkhuijs
J M
JM
van Dongen
J J M
JJ
D001854:Bone Marrow Cells / Q000737:chemistry / Q000473:pathology; D004273:DNA, Neoplasm / Q000032:analysis / Q000235:genetics*; D005189:False Positive Reactions; D015322:Gene Rearrangement, B-Lymphocyte; D015329:Gene Rearrangement, T-Lymphocyte; D006801:Humans; D018365:Neoplasm, Residual; D016133:Polymerase Chain Reaction / Q000379:methods*; D017410:Practice Guidelines as Topic; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics / Q000473:pathology* / Q000628:therapy; D013997:Time Factors
D004273:DNA, Neoplasm